Literature DB >> 11884350

Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness.

William G Honer1, Peter Falkai, Thomas A Bayer, Jane Xie, Lily Hu, Hong-Ying Li, Victoria Arango, J John Mann, Andrew J Dwork, William S Trimble.   

Abstract

A fundamental molecular component of neural connectivity is the SNARE (SNAP receptor) protein complex, which consists of three proteins, syntaxin, SNAP-25 and VAMP. Under appropriate conditions, the SNARE complex can be formed in vitro. To investigate the hypothesis that dysregulation of SNARE proteins or their interactions could be abnormal in severe mental disorders, the three SNARE proteins and the complex were studied in post-mortem anterior frontal cortex homogenates. An ELISA was used to quantify SNARE protein immunoreactivities in cortical homogenates from four groups: patients with schizophrenia who died of causes other than suicide (n = 6), patients with schizophrenia and suicide (n = 7), patients with depression and suicide (n = 11), and controls (n = 11). Differences between groups in patterns of SNARE protein immuno-reactivities were demonstrated [Wilks' Lambda F(9,68) = 3.57, P = 0.001]. Protein-by-protein analyses indicated a significant reduction in SNAP-25 immunoreactivity in the schizophrenia non-suicide group [28% decrease relative to controls, F(3,31) = 6.45, P = 0.002, Student-Newman-Keuls test, P < 0.01]. The intercorrelations between SNARE protein and synaptophysin immunoreactivities were high in controls, but lower in the other groups, further indicating disturbances in relationships between these proteins. The extent of SNARE complex formation in vitro was studied using immuno-blotting. Significant differences related to group membership were observed for the SNARE complexes identified by SNAP-25 [Wilks' Lambda F(3,31) = 4.76, P = 0.008] and by syntaxin immunostaining [Wilks' Lambda F(3,31) = 9.16, P = 0.0002]. In both groups with suicide as a cause of death, relatively more SNAP-25 and syntaxin was present in the heterotrimeric SNARE complex than in other molecular forms. These abnormalities in the SNARE complex could represent a molecular substrate for abnormalities of neural connectivity in severe mental disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884350     DOI: 10.1093/cercor/12.4.349

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  50 in total

1.  Amyloid-β Oligomers May Impair SNARE-Mediated Exocytosis by Direct Binding to Syntaxin 1a.

Authors:  Yoosoo Yang; Jaewook Kim; Hye Yun Kim; Nayeon Ryoo; Sejin Lee; YoungSoo Kim; Hyewhon Rhim; Yeon-Kyun Shin
Journal:  Cell Rep       Date:  2015-08-13       Impact factor: 9.423

2.  Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia.

Authors:  Alfredo Ramos-Miguel; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Alasdair M Barr; William G Honer
Journal:  Biol Psychiatry       Date:  2014-12-19       Impact factor: 13.382

3.  Reduced SNAP25 Protein Fragmentation Contributes to SNARE Complex Dysregulation in Schizophrenia Postmortem Brain.

Authors:  Alfredo Ramos-Miguel; Kristina Gicas; Jehan Alamri; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Fang Cai; Weihong Song; Alasdair M Barr; William G Honer
Journal:  Neuroscience       Date:  2018-12-21       Impact factor: 3.590

4.  Genome-wide association scan for five major dimensions of personality.

Authors:  A Terracciano; S Sanna; M Uda; B Deiana; G Usala; F Busonero; A Maschio; M Scally; N Patriciu; W-M Chen; M A Distel; E P Slagboom; D I Boomsma; S Villafuerte; E Sliwerska; M Burmeister; N Amin; A C J W Janssens; C M van Duijn; D Schlessinger; G R Abecasis; P T Costa
Journal:  Mol Psychiatry       Date:  2008-10-28       Impact factor: 15.992

5.  Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder.

Authors:  Falk W Lohoff; Andrew E Weller; Paul J Bloch; Aleksandra H Nall; Thomas N Ferraro; Wade H Berrettini
Journal:  J Neural Transm (Vienna)       Date:  2008-07-30       Impact factor: 3.575

6.  Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Naruya Saitou; Takashi Kitano; Bryan J Mowry; Raymond R Crowe; Jeremy M Silverman; Douglas F Levinson; Pablo V Gejman
Journal:  Am J Hum Genet       Date:  2004-08-24       Impact factor: 11.025

7.  IsoDOT Detects Differential RNA-isoform Expression/Usage with respect to a Categorical or Continuous Covariate with High Sensitivity and Specificity.

Authors:  Wei Sun; Yufeng Liu; James J Crowley; Ting-Hued Chen; Hua Zhou; Haitao Chu; Shunping Huang; Pei-Fen Kuan; Yuan Li; Darla R Miller; Ginger D Shaw; Yichao Wu; Vasyl Zhabotynsky; Leonard McMillan; Fei Zou; Patrick F Sullivan; Fernando Pardo-Manuel de Villena
Journal:  J Am Stat Assoc       Date:  2015-11-07       Impact factor: 5.033

8.  Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia.

Authors:  Akin Oni-Orisan; Lars V Kristiansen; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Biol Psychiatry       Date:  2007-12-26       Impact factor: 13.382

9.  Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk.

Authors:  Peter L Oliver; Kay E Davies
Journal:  Hum Mol Genet       Date:  2009-09-03       Impact factor: 6.150

10.  Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants.

Authors:  Laura Musazzi; Marco Milanese; Pasqualina Farisello; Simona Zappettini; Daniela Tardito; Valentina S Barbiero; Tiziana Bonifacino; Alessandra Mallei; Pietro Baldelli; Giorgio Racagni; Maurizio Raiteri; Fabio Benfenati; Giambattista Bonanno; Maurizio Popoli
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.